Searched for
SUN PHARMA Q4 RESULT PREVIEW
MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Crude at $100, AI IPOs at $1 trillion, and gold on sale: What Peter McGuire says you should do nowPeter McGuire of Australia-Trading.com highlights a chaotic market driven by rumors and geopolitics, not fundamentals. He predicts crude oi...
- Bonus issue alert! Brigade Enterprises sets record date for 1:3 bonus share rewardBrigade Enterprises has fixed June 17 as the record date for its 1:3 bonus share issue after receiving shareholder approval through an e-vo...
- What is Planet Nine, and where is it? Mystery of large hidden planet beyond Neptune explainedWhat is Planet Nine, and where is it? The question has fascinated astronomers for years. Scientists believe a massive undiscovered planet m...
- The AI play no one is talking about: Why BofA is snapping up power & metals instead of ITBofA Securities India's Amish Shah advises shifting from IT to infrastructure, citing a 'dangerous gap' in consensus earnings forecasts. He...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...
- JM Financial shares tank 8% as Q4 net profit declines 31% to Rs 162 croreJM Financial's shares plunged 8% following a significant drop in fourth-quarter net revenue and profit. While full-year profit after tax sa...
- Buy financials, healthcare, and manufactured exports; Pramod Gubbi on investing in a tricky marketIndia's Q4 earnings show recovery signs, with Nifty 100 profits up 13%. However, macro headwinds like rising crude oil prices and a depreci...
- IndiGo Q4 Results: Co reports loss of Rs 2,536 crore vs profit a year agoIndiGo Q4 Results: Budget carrier IndiGo faced a tough fourth quarter in FY26, reporting a net loss of Rs 2,536 crore. Revenue saw a slight...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Asian Paints Q4 Results: Net profit surges 69% YoY to Rs 1,172 crore, revenue rises 11%Asian Paints announced strong Q4 FY26 results. Net profit surged 69% to Rs 1,172 crore. Revenue from operations grew 11% to Rs 9,228.46 cro...
- Pine Labs Q4 Results: Co turns to black, logs Rs 59 crore profit on 17% revenue jumpPine Labs Q4 Results: Payments solutions provider Pine Labs turned profitable in the March-ended quarter, posting a consolidated net profit...
- Suzlon Energy Q4 Results: Profit falls 6% YoY to Rs 1,114 crore despite 45% revenue surgeSuzlon Energy Q4 Results: Revenue from operations, however, increased 45% YoY to Rs 5,468 crore.
- Hindalco Q4 Results: Profit falls 51% YoY to Rs 2,597 crore; co declares Rs 5 dividendHindalco Q4 Results: Hindalco on Friday reported a 51% year-on-year (YoY) decline in its consolidated net profit at Rs 2,597 crore in the f...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
Load More
